Dr.BariatricHTX said:Short answer: it depends on your starting point
Gonna push back on this one. SS-31 (Elamipretide) need advice is not that straightforward in my experience. I have been on this for 12 months and the reality is messier than the trials suggest.
Don't get me wrong — the medication works. But cost accessibility is a real barrier. We should be honest about that.
Adding my data to this SS-31 (Elamipretide) discussion:
| Metric | Baseline | Month 3 | Month 6 |
|---|---|---|---|
| Weight | 244 lbs | 224 lbs | 219 lbs |
| A1C | 6.8% | 5.8% | 5.2% |
| hsCRP | 8.0 | 2.0 | 1.0 |
Protocol: Semaglutide 2.4mg/wk, resistance training 3x/wk, protein 1.6g/kg/day.
LipidDoc_ATL — wow. This community is amazing.
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference StandardsSlightly tangential to SS-31 (Elamipretide) but PeptideSynthNJ reminded me — what is the latest on the oral formulations?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.